- Home
- KRYS vs EQX Comparison
KRYS vs EQX Comparison
Compare KRYS & EQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- EQX
- Stock Information
- Founded
- KRYS 2015
- EQX 2007
- Country
- KRYS United States
- EQX Canada
- Employees
- KRYS N/A
- EQX N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- EQX Precious Metals
- Sector
- KRYS Health Care
- EQX Basic Materials
- Exchange
- KRYS Nasdaq
- EQX Nasdaq
- Market Cap
- KRYS 3.8B
- EQX 3.2B
- IPO Year
- KRYS 2017
- EQX N/A
- Fundamental
- Price
- KRYS $143.08
- EQX $5.80
- Analyst Decision
- KRYS Strong Buy
- EQX
- Analyst Count
- KRYS 9
- EQX 0
- Target Price
- KRYS $208.78
- EQX N/A
- AVG Volume (30 Days)
- KRYS 374.0K
- EQX 18.2M
- Earning Date
- KRYS 08-04-2025
- EQX 08-06-2025
- Dividend Yield
- KRYS N/A
- EQX N/A
- EPS Growth
- KRYS 109.01
- EQX N/A
- EPS
- KRYS 4.16
- EQX 0.64
- Revenue
- KRYS $333,448,000.00
- EQX $1,696,526,000.00
- Revenue This Year
- KRYS $44.05
- EQX $40.61
- Revenue Next Year
- KRYS $46.15
- EQX $14.56
- P/E Ratio
- KRYS $34.43
- EQX $9.12
- Revenue Growth
- KRYS 247.53
- EQX 54.88
- 52 Week Low
- KRYS $122.80
- EQX $4.48
- 52 Week High
- KRYS $219.34
- EQX $7.45
- Technical
- Relative Strength Index (RSI)
- KRYS 57.50
- EQX 37.70
- Support Level
- KRYS $135.86
- EQX $5.66
- Resistance Level
- KRYS $143.44
- EQX $5.95
- Average True Range (ATR)
- KRYS 5.15
- EQX 0.20
- MACD
- KRYS 1.07
- EQX -0.05
- Stochastic Oscillator
- KRYS 80.33
- EQX 16.89
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About EQX Equinox Gold Corp.
Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the United States, Mexico, and Brazil. The majority of its revenue is generated from Canada.